# Sexual Penetration Pain in Postmenopausal Women: A Topical Botanical Drug Treatment

> **NCT03682601** · PHASE2 · TERMINATED · sponsor: **GTO Pharmaceutical, LLC** · enrollment: 32 (actual)

## Conditions studied

- Sexual Pain Disorders
- Postmenopausal Symptoms
- Vulvovaginal Atrophy
- Female Sexual Dysfunction
- Dyspareunia
- Vulvodynia
- Vestibulodynia
- Arousal Disorders, Sexual
- Genito-Pelvic Pain/Penetration Disorder
- Female Sexual Arousal Disorder

## Interventions

- **DRUG:** 5% sinecatechins ointment
- **DRUG:** Placebo
- **DRUG:** 10% sinecatechins ointment

## Key facts

- **NCT ID:** NCT03682601
- **Lead sponsor:** GTO Pharmaceutical, LLC
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-08-30
- **Primary completion:** 2021-02-12
- **Final completion:** 2021-02-13
- **Target enrollment:** 32 (ACTUAL)
- **Why stopped:** pandemic
- **Last updated:** 2022-07-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03682601

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03682601, "Sexual Penetration Pain in Postmenopausal Women: A Topical Botanical Drug Treatment". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03682601. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
